Who
Robert Ross Carter
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, The Oncology Institute.
In numbers
- Trades disclosed
- 20
- Buys
- 1
- Sells
- 1
- Bought
- $9,418
- Sold
- $1,759
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 20 Nov 2024
- Last trade
- 21 May 2026
- Last filed
- 22 May 2026
Companies traded
Activity over time
1 Mar 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 21 May 2026filed 22 May 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code J | $7,1701,604 at $4.47 | filing |
| 21 May 2026filed 22 May 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code J | $7,1701,604 at $4.47 | filing |
| 27 Mar 2026filed 1 Apr 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code A | —202,914 at $0.00 | filing |
| 27 Mar 2026filed 1 Apr 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code J | $62K20,320 at $3.07 | filing |
| 27 Mar 2026filed 1 Apr 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code A | —202,914 at $0.00 | filing |
| 27 Mar 2026filed 1 Apr 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code J | $62K20,320 at $3.07 | filing |
| 17 Mar 2026filed 18 Mar 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code J | $4,7171,314 at $3.59 | filing |
| 17 Mar 2026filed 18 Mar 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code J | $4,7171,314 at $3.59 | filing |
| 2 Jan 2026filed 6 Jan 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code J | $895244 at $3.67 | filing |
| 2 Jan 2026filed 6 Jan 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code J | $895244 at $3.67 | filing |
| 2 Jan 2026filed 5 Jan 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Sold | $879247 at $3.56 | filing |
| 2 Jan 2026filed 5 Jan 2026 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Sold | $879247 at $3.56 | filing |
| 17 Nov 2025filed 19 Nov 2025 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code A | —195 at $0.00 | filing |
| 21 May 2025filed 22 May 2025 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code D | $4,2911,601 at $2.68 | filing |
| 31 Mar 2025filed 2 Apr 2025 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code A | —197,368 at $0.00 | filing |
| 26 Mar 2025filed 28 Mar 2025 | The Oncology Instituteoption or derivative · Providers & Facilities | SEC FORM 4 Code P | $5894,528 at $0.13 | filing |
| 26 Mar 2025filed 28 Mar 2025 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Bought | $9,4189,056 at $1.04 | filing |
| 19 Mar 2025filed 20 Mar 2025 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code D | $1,0241,150 at $0.89 | filing |
| 6 Jan 2025filed 7 Jan 2025 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code D | $88258 at $0.34 | filing |
| 20 Nov 2024filed 21 Nov 2024 | The Oncology InstituteProviders & Facilities | SEC FORM 4 Code D | $33235 at $0.14 | filing |
News
No headline names them, or the companies they trade most, lately.